PolyTechnos Venture Partners

Total investments

28

Average round size

15M

Portfolio companies

13

Rounds per year

1.17

Lead investments

2

Follow on index

0.54

Exits

3

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareManufacturingPharmaceuticalHardwareSemiconductorElectronicsTelecommunicationsOptical Communication

Summary

PolyTechnos Venture Partners is the famous VC, which was founded in 1998. The fund was located in Europe if to be more exact in Germany. The leading representative office of defined VC is situated in the Munich.

This organization was formed by Dirk Kanngiesser. The overall number of key employees were 3.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the PolyTechnos Venture Partners, startups are often financed by Sofinnova Partners, Walden Israel Venture Capital, Eurofund. The meaningful sponsors for the fund in investment in the same round are Walden Israel Venture Capital, Eurofund, Vertex Ventures Israel. In the next rounds fund is usually obtained by Gemini Israel Ventures, Walden Israel Venture Capital, Vertex Ventures Israel.

Opposing the other organizations, this PolyTechnos Venture Partners works on 18 percentage points less the average amount of lead investments. The important activity for fund was in 2006. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2009. Considering the real fund results, this VC is 13 percentage points less often commits exit comparing to other organizations. The average startup value when the investment from PolyTechnos Venture Partners is 10-50 millions dollars.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Electronics. Among the various public portfolio startups of the fund, we may underline Plastic Logic Germany, Addex Therapeutics, NemeriX For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. The fund has exact preference in some founders of portfolio startups.

Show more

Investments analytics

Analytics

Total investments
28
Lead investments
2
Exits
3
Rounds per year
1.17
Follow on index
0.54
Investments by industry
  • Manufacturing (15)
  • Health Care (8)
  • Telecommunications (7)
  • Biotechnology (6)
  • Pharmaceutical (6)
  • Show 32 more
Investments by region
  • Switzerland (5)
  • United States (4)
  • Germany (8)
  • Israel (5)
  • Ireland (3)
  • Show 1 more
Peak activity year
2007

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
82M
Group Appearance index
0.93
Avg. company exit year
10
Avg. multiplicator
6.87
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Innolume 15 Jun 2006 Manufacturing, Telecommunications, Guides Early Stage Venture 9M Germany, North Rhine-Westphalia, Dortmund
Jerini 13 Nov 2001 Biotechnology, Pharmaceutical, Clinical Trials Early Stage Venture 23M Berlin, Berlin, Germany

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.